Acta Laser Biology Sinica, Volume. 33, Issue 4, 377(2024)
Dexmedetomidine Regulates the PI3K/AKT Signaling Pathway to Improve Lipopolysaccharide-induced Colitis Colon Epithelial Cell Injury
[1] [1] DU L, HA C. Epidemiology and pathogenesis of ulcerative colitis[J]. Gastroenterology Clinics of North America, 2020, 49(4): 643-654.
[2] [2] KAENKUMCHORN T, WAHBEH G. Ulcerative colitis: making the diagnosiss[J]. Gastroenterology Clinics of North America, 2020, 49(4): 655-669.
[3] [3] TASBIHGOU S, BARENDS C, ABSALOM A, et al. The role of dexmedetomidine in neurosurgery[J]. Best Practice & Research-Clinical Anaesthesiology, 2021, 35(2): 221-229.
[6] [6] LIU B, PIAO X, NIU W, et al. Kuijieyuan decoction improved intestinal barrier injury of ulcerative colitis by affecting TLR4-dependent PI3K/AKT/NF-B oxidative and inflammatory signaling and gut microbiota[J]. Frontiers in Pharmacology, 2020, 11: 1036.
[7] [7] ZHAO Y, FENG X, LI B, et al. Dexmedetomidine protects against lipopolysaccharide-induced acute kidney injury by enhancing autophagy through inhibition of the PI3K/AKT/mTOR pathway[J]. Frontiers in Pharmacology, 2020, 11: 128.
[11] [11] SMILLIE C, BITON M, SULLIVAN K, et al. Intra-and inter-cellular rewiring of the human colon during ulcerative colitis[J]. Cell, 2019, 178(3): 714-730.
[12] [12] REN M, GU M, ZHOU X, et al. Sirtuin 1 alleviates endoplasmic reticulum stress-mediated apoptosis of intestinal epithelial cells in ulcerative colitis[J]. World Journal of Gastroenterology, 2019, 25(38): 5800-5813.
[13] [13] KEATING G. Dexmedetomidine: a review of its use for sedation in the intensive care setting[J]. Drugs, 2015, 75(10): 1119-1130.
[16] [16] SUN X, CHEN L, HE Z, et al. PI3K/Akt-Nrf2 and anti-inflammation effect of macrolides in chronic obstructive pulmonary disease[J]. Current Drug Metabolism, 2019; 20(4): 301-304.
[17] [17] LI M, LUO H, WU X, et al. Anti-Inflammatory effects of huangqin decoction on dextran sulfate sodium-induced ulcerative colitis in mice through regulation of the gut microbiota and suppression of the Ras-PI3K-Akt-HIF-1 and NF-B pathways[J]. Frontiers in Pharmacology, 2020, 10: 1552.
[18] [18] SHI L, GUO C, XIE Y, et al. Dexmedetomidine attenuates lung injury in obstructive jaundice rats through PI3K/Akt/HIF-1 signaling pathway[J]. Archives of Medical Research, 2019, 50(5): 233-240.
Get Citation
Copy Citation Text
DONG Jianglong, SONG Wanjun, SHAN Xin, TONG Yefeng. Dexmedetomidine Regulates the PI3K/AKT Signaling Pathway to Improve Lipopolysaccharide-induced Colitis Colon Epithelial Cell Injury[J]. Acta Laser Biology Sinica, 2024, 33(4): 377
Category:
Received: Oct. 23, 2023
Accepted: Dec. 20, 2024
Published Online: Dec. 20, 2024
The Author Email: Jianglong DONG (dong13131139331@163.com)